| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $4.07 (Beat by $1.35) |
| EPS GAAP Actual | $4.07 (Beat by $1.35) |
| Revenue Actual | $32.846B |
| Revenue Surprise | Beat by $32846M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 17.65 | 11.5 | 12.75668 | 22.79007 | 2 |
| Dec 2028 | 13.75 | 14.76 | 8.99226 | 17.48715 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.13 | 5.13 | 32.846B | -1.89% | 32846M |
| FQ3 2025 (Sep 2025) | 0.0148 | 0.0148 | 35.849B | 1.33% | 35849M |
| FQ2 2025 (Jun 2025) | 3.9576 | 3.9576 | 33.66B | -13.97% | 33660M |
| FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 31.85B | -3.57% | 31850M |
| FQ4 2024 (Dec 2024) | 2.45 | 2.45 | 33.466B | -8.58% | 33466M |
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 35.373B | -17.56% | 35373M |
| FQ2 2024 (Jun 2024) | 4.34 | 4.34 | 38.362B | 4.01% | 38362M |
| FQ1 2024 (Mar 2024) | 2.58 | 2.58 | 32.987B | -6.34% | 32987M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 2.1391 | -- | 1.25365 | 2.87829 | 5 |
| FQ3 2028 (Sep 2028) | 4.6579 | -- | 2.72982 | 6.2675 | 5 |
| FQ2 2028 (Jun 2028) | 7.0952 | -- | 4.15823 | 9.54704 | 5 |
| FQ1 2028 (Mar 2028) | 6.241 | -- | 3.65762 | 8.39766 | 5 |
| FQ4 2027 (Oct 2027) | 5.8792 | -- | 3.73256 | 7.23471 | 4 |
| FQ3 2027 (Jul 2027) | 6.5993 | -- | 4.18973 | 8.12083 | 3 |
| FQ2 2027 (Jun 2027) | 5.00284 | -- | 2.93198 | 6.73164 | 4 |
| FQ1 2027 (Mar 2027) | 0.6775 | -- | 0.43013 | 0.8337 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 30.82B | -- | 21.01B | 39.01B | 1 |
| FQ3 2028 (Sep 2028) | 32.83B | -- | 22.38B | 41.56B | 1 |
| FQ2 2028 (Jun 2028) | 34.02B | -- | 23.18B | 43.06B | 1 |
| FQ1 2028 (Mar 2028) | 31.18B | -- | 21.25B | 39.47B | 1 |
| FQ4 2027 (Oct 2027) | 55.99B | -- | 40.26B | 65.92B | 2 |
| FQ3 2027 (Jul 2027) | 53.88B | -- | 38.75B | 63.44B | 2 |
| FQ2 2027 (Jun 2027) | 34.11B | -- | 23.25B | 43.18B | 2 |
| FQ1 2027 (Mar 2027) | 51.85B | -- | 37.29B | 61.05B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.13 | 5.13 | 100% | |
| FQ3 2025 (Sep 2025) | 0.0148 | 0.0148 | 100% | |
| FQ2 2025 (Jun 2025) | 3.9576 | 3.9576 | 100% | |
| FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 100% | |
| FQ4 2024 (Dec 2024) | 2.45 | 2.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 100% | |
| FQ2 2024 (Jun 2024) | 4.34 | 4.34 | 100% | |
| FQ1 2024 (Mar 2024) | 2.58 | 2.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $32.85B | $32846M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $35.85B | $35849M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $33.66B | $33660M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $31.85B | $31850M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $33.47B | $33466M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $35.37B | $35373M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $38.36B | $38362M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $32.99B | $32987M | 100% |